首页> 外文OA文献 >PP132—Contribution of genetic (CYP3A5, ABCB1 and POR) and non-genetic variables to the oral tacrolimus clearance in children’s with stable kidney transplant, during advagraf® treatment

【2h】

PP132—Contribution of genetic (CYP3A5, ABCB1 and POR) and non-genetic variables to the oral tacrolimus clearance in children’s with stable kidney transplant, during advagraf® treatment

机译：PP132-在advagraf®治疗期间，遗传因素（CYP3A5，ABCB1和POR）和非遗传变量对稳定肾移植患儿口服他克莫司清除率的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Almeida-Paulo G.N.; Lubomirov R.; Alonso-Sanchez N.L.; Espinosa L.; Carcas A.J.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant. [J] . G N Almeida-Paulo, I Dapía García, R Lubomirov, The pharmacogenomics journal . 2018,第1期

机译：ABCB1和POR基因的重量在CYP3A5中口腔肾脏移植口口腔Tacrolimus暴露中的重量。
2. CYP3A5*3 CYP3A5*3 and ABCB1 ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney Transplantation [J] . Hu Rong, Barratt Daniel T., Coller Janet K., Basic & clinical pharmacology & toxicology. . 2018,第3期

机译：CYP3A5 * 3 CYP3A5 * 3和ABCB1 ABCB1 61A> G显着影响肾上前三个月的剂量调整的槽血巨蜥浓度
3. CYP3A5*3 CYP3A5*3 and ABCB1 ABCB1 61A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney Transplantation [J] . Hu Rong, Barratt Daniel T., Coller Janet K., Basic & clinical pharmacology & toxicology. . 2018,第Suppla1期

机译：CYP3A5 * 3 CYP3A5 * 3和ABCB1 ABCB1 61A> G显着影响肾上前三个月的剂量调整的槽血巨蜥浓度
4. ABCB1 and IMPDH functional and genetic contributions to tacrolimus and mycophenolic acid therapy in transplant patients [D] . Wang, Jian. 2007

机译：ABCB1和IMPDH在他克莫司和麦考酚酸治疗中的功能和遗传贡献
5. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients [O] . Diego Alberto C Cusinato, Riccardo Lacchini, Elen A Romao, 2014

机译：CYP3A5基因型和ABCB1双型与他克莫司治疗的关系
6. SAFE CONVERSION OF STABLE KIDNEY TRANSPLANT RECIPENTS FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCE-DAILY MODIFIED RELEASE TACROLIMUS (Advagraf) [O] . Carmellini M, Ruggieri G, Collini A 2011

机译：从每日一次的TaCROLImUs（prograf）到每日改良的释放TaCROLImUs（advagraf）的稳定肾脏移植配方的安全转换

PP132—Contribution of genetic (CYP3A5, ABCB1 and POR) and non-genetic variables to the oral tacrolimus clearance in children’s with stable kidney transplant, during advagraf® treatment

著录项

相似文献

相关主题

期刊订阅